Study identifies factors that predict driving cessation in seniors
May 22, 2024
Older age, female sex and progression to symptomatic Alzheimer’s disease were associated with driving cessation.
Facility staff and families both struggle to figure out processes for dementia patients, report reveals
By
Kimberly Bonvissuto
Mar 20, 2024
It’s not just family caregivers who face challenges navigating dementia care — the nation’s healthcare workers also said they had difficulties providing care coordination through a complex healthcare...
Nonwhite adults with cognitive impairment more likely to live in polluted areas
May 21, 2024
The authors say that clinical trials should consider environmental exposures and injustices.
As more seniors turn to music therapy, health insurer says it will help payers find their groove
By
Aaron Dorman
Nov 02, 2023
Longevity Health will now provide coverage for a platform that provides music therapy via singing to senior living communities.
Mild cognitive impairment underdiagnosed
Nov 21, 2023
Only 0.1% of clinicians and practices have diagnosis rates within the expected range.
More news for Friday, Nov. 3
By
Kimberly Bonvissuto
Nov 03, 2023
Neighoborhood environments can influence modifiable factors for Alzheimer’s, dementias … Former assisted living owner to undergo competency evaluation in exploitation case … Enhanced tai chi program...
Thyrotoxicosis linked to risk for incident cognitive disorder
Dec 28, 2023
Exogenous thyrotoxicosis remained a significant risk factor for cognitive disorders when stratified by cause and severity.
Panel of 48 CSF proteins complements existing Alzheimer’s biomarkers
Sep 07, 2023
The CSF 48 panel plus existing biomarkers significantly improved the diagnostic performance for the outcomes studied.
Symptoms, negative life impact seen during, after benzodiazepine use
Aug 08, 2023
The authors dub the term benzodiazepine-induced neurological dysfunction to describe neurological complications.
Monoclonal antibodies provide small benefits in Alzheimer’s disease
Jan 26, 2024
Harms include increased risks for amyloid-related imaging abnormalities (ARIA)-edema, ARIA-hemorrhage and symptomatic ARIA-edema.